NEW YORK--(BUSINESS WIRE)--Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced Astellas Pharma Inc. has chosen Medidata Rave 5.5 as its standard global solution for all clinical studies in Phases I-III over the next five years. Due to Medidata’s global reach, comprehensive support services and unique product scalability, Astellas plans to implement clinical trials using Medidata Rave 5.5 across North America, Asia, Europe and other regions.
